Cancer Activation And Protein 'Chatter' Linked

Main Category: Cancer / Oncology
Also Included In: Genetics
Article Date: 16 Aug 2007 - 4:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

Scientists have found the existence of cross-talk between human chromosome ends and the protein complexes central to the stability of the entire human genome, a 'chat' that contributes to cancer development.

The research, published in Nature Structural & Molecular Biology, sheds new light on the pathology of three related but non-curable cancer-predisposed human disorders: ataxia telangiectasia, ataxia telangiectasia-like disorder, and Nijmegen breakage syndrome.

"The proteins whose deficiency is responsible for these three human disorders have the job of ensuring that chromosome ends are maintained and protected," says Xu-Dong Zhu, assistant professor of biology and the lead author on the study. "As we age, our chromosome ends become shorter. Individuals whose ends deteriorate faster are at a higher risk of developing cancer because short chromosome ends are a serious threat to the stability of our genome. When the genome becomes unstable, it puts our bodies at greater risk of cancer."

Zhu adds that patients with ataxia telangiectasia, ataxia telangiectasia-like disorder, and Nijmegen breakage syndrome experience an accelerated rate of loss of DNA from chromosome ends. "We didn't know why this happens; now we have found that the communication link between these proteins and a protein crucial for maintenance of chromosome ends is either missing or nonfunctional in these patients."

Zhu further explains that lack of this cross talk in normal cells promotes short chromosome ends and as a result promotes cancer formation. A key difference between cancer cells and normal cells is that the former maintain their chromosome ends and have the unlimited potential to grow. Disruption of this communication in cancer cells induces shortening of chromosome ends and may restrict their potential to grow.

Zhu says that the discovery will help researchers understand the onset and progression of these diseases as well as help them find a cure for cancer.

----------------------------
Article adapted by Medical News Today from original press release.
----------------------------

According to the U.S. National Cancer Institute, ataxia telangiectasia (AT), the most common form of the three disorders, affects one in 40,000-100,000 people. Patients with this disease are at least 37 times more likely to develop any cancer than individuals in the general population. The risk of developing lymphoid tumors is 100 times greater in these patients than in the general population. AT patients are often wheelchair-bound by their teens and die by the time they reach their twenties.

Funding for the study was provided by the Canadian Institutes of Health Research (CIHR) and the Natural Sciences and Engineering Research Council. Zhu is a new investigator with CIHR.

McMaster University, a world-renowned, research-intensive university, fosters a culture of innovation, and a commitment to discovery and learning in teaching, research and scholarship. Based in Hamilton, the University, one of only four Canadian universities to be listed on the Top 100 universities in the world, has a student population of more than 23,000, and an alumni population of more than 125,000 in 125 countries.

Source: Jane Christmas
McMaster University